<DOC>
	<DOCNO>NCT00689832</DOCNO>
	<brief_summary>Children atopic eczema poor response topical corticosteroid apply either Protopic Fluticasone ointment twice day 3 week . They could continue 3 week day need .</brief_summary>
	<brief_title>Protopic Ointment Children Atopic Eczema</brief_title>
	<detailed_description>Treatments apply twice daily clearance , maximum 3 week , case uncleared residual lesion , daily 3 week . In event flare-up treatment resume twice day end study . Statistical method : An interim analysis perform 30 % plan total sample size , i.e . 140 include patient complete study , reassess assumption make plan phase .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Children moderate severe atopic dermatitis ( Rajka &amp; Langeland score great equal 4.5 ) respond insufficiently conventional therapy Female patient childbearing age : effective mean contraception throughout period study four week follow end study Informed consent Therapeutic washout atopic dermatitis treatment Genetic epidermal barrier defect , Netherton 's syndrome , suffer erythroderma Any female patient pregnant breastfeed Clinical infection due VZV virus ( varicella , zona ) , HSV12 viruses ( herpes ) , verruca vulgaris molluscum contagiosum Superinfected eczema Known hypersensitivity macrolides excipient tacrolimus ointment Known hypersensitivity one agent contain fluticasone 0.005 % ointment preparation Ulcerated lesion , whatever type Moderate severe acne rosacea Patients participate time another clinical study participate another clinical study within 28 day start study substance abuse ( include drug alcohol ) mental disorder/psychological state , investigator 's opinion , might interfere patient 's followup Known serologically proven HIV positivity</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Dermatitis , Atopic</keyword>
	<keyword>Dermatologic Agents</keyword>
	<keyword>Topical Drug Administration</keyword>
	<keyword>Tacrolimus</keyword>
	<keyword>Calcineurin</keyword>
	<keyword>Corticosteroid</keyword>
	<keyword>Fluticasone propionate</keyword>
	<keyword>Child</keyword>
</DOC>